Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A20460 | 25947915 | Biol Pharm Bull | The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease. | 2015 | Details |
| A20463 | 25945652 | Cell Cycle | Modulation of insulin degrading enzyme activity and liver cell proliferation. | 2015 | Details |
| A20468 | 25941433 | J Clin Exp Hepatol | Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology. | 2015 | Details |
| A20471 | 25940690 | Food Funct | Salicylic acid elicitation during cultivation of the peppermint plant improves anti-diabetic effects of its infusions. | 2015 | Details |
| A20476 | 25938357 | Pathology | Increased apolipoprotein A5 expression in human and rat non-alcoholic fatty livers. | 2015 | Details |
| A20477 | 25937862 | World J Hepatol | Non-alcoholic fatty liver disease: The diagnosis and management. | 2015 | Details |
| A20486 | 25933096 | PLoS One | OXPHOS-Mediated Induction of NAD+ Promotes Complete Oxidation of Fatty Acids and Interdicts Non-Alcoholic Fatty Liver Disease. | 2015 | Details |
| A20487 | 25933030 | PLoS One | Serum Chemerin Concentrations Associate with Beta-Cell Function, but Not with Insulin Resistance in Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD). | 2015 | Details |
| A20492 | 25925168 | Lipids Health Dis | Amount of hepatic fat predicts cardiovascular risk independent of insulin resistance among Hispanic-American adolescents. | 2015 | Details |
| A20494 | 25922835 | Biomed Res Int | Antiresistin RNA Oligonucleotide Ameliorates Diet-Induced Nonalcoholic Fatty Liver Disease in Mice through Attenuating Proinflammatory Cytokines. | 2015 | Details |
| A20497 | 25921668 | Clin Liver Dis | Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma. | 2015 | Details |
| A20500 | 25920182 | Invest Clin | [Tests of liver function in obese school children]. | 2015 | Details |
| A20501 | 25920092 | J Hepatol | Current efforts and trends in the treatment of NASH. | 2015 | Details |
| A20502 | 25920090 | J Hepatol | NAFLD: a multisystem disease. | 2015 | Details |
| A20503 | 25919774 | Eur J Gastroenterol Hepatol | Bariatric surgery and nonalcoholic fatty liver disease. | 2015 | Details |
| A20506 | 25917783 | Gastroenterology | Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients. | 2015 | Details |
| A20511 | 25915484 | Curr Drug Targets | Antioxidant Mechanisms in Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20514 | 25914480 | World J Gastroenterol | Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease. | 2015 | Details |
| A20518 | 25913781 | Endocr J | Gamma-glutamyl transferase is associated with sarcopenia and sarcopenic obesity in community-dwelling older adults: results from the Fifth Korea National Health and Nutrition Examination Survey, 2010-2011. | 2015 | Details |
| A20524 | 25910377 | Turk J Gastroenterol | Carotid intima-media thickness and flow-mediated dilation in obese children with non-alcoholic fatty liver disease. | 2014 | Details |
| A20525 | 25910371 | Turk J Gastroenterol | The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study. | 2014 | Details |
| A20531 | 25906757 | J Endocrinol Invest | 1,25(OH)2D3 downregulates the Toll-like receptor 4-mediated inflammatory pathway and ameliorates liver injury in diabetic rats. | 2015 | Details |
| A20532 | 25906661 | Lik Sprava | [Correlation of adiponectin in patients with type 2 diabetes with nonalcoholic fatty liver disease depending on transaminases level]. | 2015 | Details |
| A20535 | 25905791 | Food Funct | Differences and similarities in hepatic lipogenesis, gluconeogenesis and oxidative imbalance in mice fed diets rich in fructose or sucrose. | 2015 | Details |
| A20544 | 25897647 | Crit Rev Food Sci Nutr | The potential of flavonoids in the treatment of non-alcoholic fatty liver disease. | 2017 | Details |
| A20545 | 25896720 | Pharmacology | Fenofibrate treatment attenuated chronic endoplasmic reticulum stress in the liver of nonalcoholic fatty liver disease mice. | 2015 | Details |
| A20547 | 25894944 | Curr Diab Rep | Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms. | 2015 | Details |
| A20548 | 25894568 | Clin Exp Med | Severity of non-alcoholic fatty liver disease is associated with high systemic levels of tumor necrosis factor alpha and low serum interleukin 10 in morbidly obese patients. | 2015 | Details |
| A20552 | 25892859 | World J Gastroenterol | Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question. | 2015 | Details |
| A20554 | 25891086 | Acta Pharmacol Sin | Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice. | 2015 | Details |
| A20556 | 25890223 | Lipids Health Dis | Serum retinol binding protein 4 is associated with visceral fat in human with nonalcoholic fatty liver disease without known diabetes: a cross-sectional study. | 2015 | Details |
| A20557 | 25889212 | J Transl Med | Docosahexaenoic acid and non-alcoholic fatty liver disease in obese children: a novel approach? | 2015 | Details |
| A20559 | 25887357 | Diabetes Care | Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD. | 2015 | Details |
| A20561 | 25885947 | J Clin Endocrinol Metab | High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels. | 2015 | Details |
| A20564 | 25881230 | BMC Gastroenterol | Deficiency of iNOS-derived NO accelerates lipid accumulation-independent liver fibrosis in non-alcoholic steatohepatitis mouse model. | 2015 | Details |
| A20565 | 25880979 | Zhonghua Gan Zang Bing Za Zhi | [Effect of apigenin on protein expressions of PPARs in liver tissues of rats with nonalcoholic steatohepatitis]. | 2015 | Details |
| A20574 | 25876706 | J Clin Immunol | Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial. | 2015 | Details |
| A20575 | 25876566 | Intern Med | Significance of oral glucose tolerance tests in non-alcoholic fatty liver disease patients with a fasting plasma glucose level of <126 mg/dL and HbA1c level of ≤ 6.4% in Japan. | 2015 | Details |
| A20576 | 25875942 | PLoS One | LPSF/GQ-02 inhibits the development of hepatic steatosis and inflammation in a mouse model of non-alcoholic fatty liver disease (NAFLD). | 2015 | Details |
| A20579 | 25875119 | Nutrients | A green algae mixture of Scenedesmus and Schroederiella attenuates obesity-linked metabolic syndrome in rats. | 2015 | Details |
| A20580 | 25873949 | Int J Endocrinol | Liver Injury Indicating Fatty Liver but Not Serologic NASH Marker Improves under Metformin Treatment in Polycystic Ovary Syndrome. | 2015 | Details |
| A20581 | 25873773 | Mediators Inflamm | OSAS-related inflammatory mechanisms of liver injury in nonalcoholic fatty liver disease. | 2015 | Details |
| A20582 | 25873639 | Gut | Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study. | 2015 | Details |
| A20584 | 25873078 | Exp Biol Med (Maywood) | Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine. | 2015 | Details |
| A20585 | 25871295 | Mar Drugs | Anti-obesity activity of the marine carotenoid fucoxanthin. | 2015 | Details |
| A20594 | 25866366 | Sci Rep | Acute exercise does not decrease liver fat in men with overweight or NAFLD. | 2015 | Details |
| A20595 | 25865747 | Obesity (Silver Spring) | Serum autotaxin is independently associated with hepatic steatosis in women with severe obesity. | 2015 | Details |
| A20596 | 25865685 | Hepatobiliary Pancreat Dis Int | Beneficial mechanisms of aerobic exercise on hepatic lipid metabolism in non-alcoholic fatty liver disease. | 2015 | Details |
| A20599 | 25864208 | Ann Hepatol | Obesity as a cause of hepatocellular carcinoma. | 2016 | Details |
| A20609 | 25852271 | World J Gastroenterol | Insulin-like growth factor-1 mRNA isoforms and insulin-like growth factor-1 receptor mRNA expression in chronic hepatitis C. | 2015 | Details |
| A20610 | 25852263 | World J Gastroenterol | Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. | 2015 | Details |
| A20613 | 25850622 | Curr Drug Targets | Identification of Lipid Species Linked to the Progression of Non-Alcoholic Fatty Liver Disease. | 2015 | Details |
| A20617 | 25849936 | PLoS One | The amelioration of hepatic steatosis by thyroid hormone receptor agonists is insufficient to restore insulin sensitivity in ob/ob mice. | 2015 | Details |
| A20620 | 25848481 | World J Hepatol | Role of diet on non-alcoholic fatty liver disease: An updated narrative review. | 2015 | Details |
| A20621 | 25848479 | World J Hepatol | Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease. | 2015 | Details |
| A20628 | 25846498 | Food Chem Toxicol | Role of hepatocyte S6K1 in palmitic acid-induced endoplasmic reticulum stress, lipotoxicity, insulin resistance and in oleic acid-induced protection. | 2015 | Details |
| A20632 | 25845417 | Liver Int | The association between the serum levels of uric acid and alanine aminotransferase in a population-based cohort. | 2015 | Details |
| A20642 | 25838034 | Metabolism | Endoplasmic Reticulum Stress Response in Non-alcoholic Steatohepatitis: The Possible Role of Physical Exercise. | 2015 | Details |
| A20647 | 25835554 | Int J Obes (Lond) | Heme oxygenase-1 gene promoter polymorphism and the risk of pediatric nonalcoholic fatty liver disease. | 2015 | Details |
| A20651 | 25832152 | Med J Aust | The imperative to prevent diabetes complications: a broadening spectrum and an increasing burden despite improved outcomes. | 2015 | Details |
| A20654 | 25829790 | Pharmacognosy Res | Psidium guajava Linn. leaf extract affects hepatic glucose transporter-2 to attenuate early onset of insulin resistance consequent to high fructose intake: An experimental study. | 2015 | Details |
| A20658 | 25824073 | Clin Med (Lond) | Non-alcoholic fatty liver disease: when to intervene and with what. | 2015 | Details |
| A20659 | 25823525 | Clin Endocrinol (Oxf) | Elevated whole blood viscosity is associated with insulin resistance and non-alcoholic fatty liver. | 2015 | Details |
| A20667 | 25818101 | Angiology | Epicardial Fat in Nonalcoholic Fatty Liver Disease: Properties and Relationships With Metabolic Factors, Cardiac Structure, and Cardiac Function. | 2015 | Details |
| A20672 | 25815106 | Oxid Med Cell Longev | P2X7 receptor as a key player in oxidative stress-driven cell fate in nonalcoholic steatohepatitis. | 2015 | Details |
| A20674 | 25810989 | J Family Med Prim Care | Nonalcoholic Fatty liver disease and risk of diabetes and cardiovascular disease: what is important for primary care physicians? | 2015 | Details |
| A20680 | 25805927 | World J Gastroenterol | Ghrelin-ghrelin O-acyltransferase system in the pathogenesis of nonalcoholic fatty liver disease. | 2015 | Details |
| A20683 | 25802723 | J Diabetes Investig | Liver steatosis is associated with insulin resistance in skeletal muscle rather than in the liver in Japanese patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A20685 | 25799683 | Arch Latinoam Nutr | [Prevalence of no alcohol fatty liver disease (NAFLD) in a population of obese children in Valencia, Venezuela]. | 2014 | Details |
| A20688 | 25798066 | Int J Biol Sci | Stem cell transplantation upregulates Sirt1 and antioxidant expression, ameliorating fatty liver in type 2 diabetic mice. | 2015 | Details |
| A20694 | 25796415 | Ultrasound Med Biol | Effects of steatosis on hepatic hemodynamics in patients with metabolic syndrome. | 2015 | Details |
| A20695 | 25795939 | Nutr Hosp | Cut-off values of waist circumference to predict metabolic syndrome in obese adolescents. | 2015 | Details |
| A20702 | 25789113 | World J Diabetes | Hepatic glycogenosis: An underdiagnosed complication of diabetes mellitus? | 2015 | Details |
| A20715 | 25784075 | Dig Dis Sci | Nonalcoholic Steatohepatitis (NASH) Is Associated with a Decline in Pancreatic Beta Cell (β-Cell) Function. | 2015 | Details |
| A20717 | 25780284 | World J Gastroenterol | Chemokine ligand 2 and paraoxonase-1 in non-alcoholic fatty liver disease: The search for alternative causative factors. | 2015 | Details |
| A20725 | 25774664 | Child Obes | Differences in Cardiometabolic Risk between Insulin-Sensitive and Insulin-Resistant Overweight and Obese Children. | 2015 | Details |
| A20726 | 25774446 | Curr Opin Gastroenterol | Nonalcoholic fatty liver disease: new treatments. | 2015 | Details |
| A20729 | 25772748 | J Gastroenterol Hepatol | Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery. | 2015 | Details |
| A20731 | 25772181 | Endocr Metab Immune Disord Drug Targets | Adiponectin as a Target in Obesity-related Inflammatory State. | 2015 | Details |
| A20732 | 25772036 | J Hepatol | Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011). | 2015 | Details |
| A20733 | 25771388 | J Pediatr | Omega-3 Fatty acids therapy in children with nonalcoholic Fatty liver disease: a randomized controlled trial. | 2015 | Details |
| A20735 | 25767880 | PLoS One | Circulating level of CTRP1 in patients with nonalcoholic fatty liver disease (NAFLD): is it through insulin resistance? | 2015 | Details |
| A20737 | 25767392 | Ther Clin Risk Manag | Therapeutic effect of hybrid training of voluntary and electrical muscle contractions in middle-aged obese women with nonalcoholic fatty liver disease: a pilot trial. | 2015 | Details |
| A20748 | 25757271 | Yao Xue Xue Bao | [Recent advances in curcumin and its derivatives for treatment of liver diseases]. | 2014 | Details |
| A20754 | 25755546 | J Clin Exp Hepatol | Metadoxine Versus Placebo for the Treatment of Non-alcoholic Steatohepatitis: A Randomized Controlled Trial. | 2014 | Details |
| A20760 | 25751727 | Int J Mol Sci | Potential epigenetic mechanism in non-alcoholic Fatty liver disease. | 2015 | Details |
| A20763 | 25748419 | Life Sci | Singular effects of PPAR agonists on nonalcoholic fatty liver disease of diet-induced obese mice. | 2015 | Details |
| A20766 | 25747354 | Am J Physiol Gastrointest Liver Physiol | Activation of the GP130-STAT3 axis and its potential implications in nonalcoholic fatty liver disease. | 2015 | Details |
| A20767 | 25745505 | Nutr Metab (Lond) | The flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice. | 2015 | Details |
| A20775 | 25742316 | Biochem J | Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity. | 2015 | Details |
| A20779 | 25740151 | Biol Rev Camb Philos Soc | De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose. | 2015 | Details |
| A20780 | 25739820 | Dig Liver Dis | Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome. | 2014 | Details |
| A20787 | 25736031 | Clin Nutr | Effect of specific amino acids on hepatic lipid metabolism in fructose-induced non-alcoholic fatty liver disease. | 2015 | Details |
| A20794 | 25729888 | J Pediatr Gastroenterol Nutr | Serum Bile Acid Levels in Children With Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20799 | 25729475 | World J Hepatol | Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease. | 2015 | Details |
| A20800 | 25729473 | World J Hepatol | Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver. | 2015 | Details |
| A20806 | 25724480 | Mol Cell Endocrinol | Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link? | 2015 | Details |
| A20807 | 25723789 | Br J Nutr | Differential effects of habitual chow-based and semi-purified diets on lipid metabolism in lactating rats and their offspring. | 2015 | Details |
| A20808 | 25721504 | Science | Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats. | 2015 | Details |
| A20810 | 25717238 | World J Gastroenterol | Mechanism of action of gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats. | 2015 | Details |